Diagnostic criteria, severity classification and guidelines of localized scleroderma

Yoshihide Asano; Manabu Fujimoto; Osamu Ishikawa; Shinichi Sato; Masatoshi Jinnin; Kazuhiko Takehara; Minoru Hasegawa; Toshiyuki Yamamoto; Hironobu Ihn

doi:10.1111/1346-8138.14161

Diagnostic criteria, severity classification and guidelines of localized scleroderma

Yoshihide Asano, Manabu Fujimoto, Osamu Ishikawa, Shinichi Sato, Masatoshi Jinnin, Kazuhiko Takehara, Minoru Hasegawa, Toshiyuki Yamamoto, Hironobu Ihn

Research output: Contribution to journal › Article › peer-review

44 Citations (Scopus)

Abstract

We established diagnostic criteria and severity classification of localized scleroderma because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for localized scleroderma, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of localized scleroderma.

Original language	English
Pages (from-to)	755-780
Number of pages	26
Journal	Journal of Dermatology
Volume	45
Issue number	7
DOIs	https://doi.org/10.1111/1346-8138.14161
Publication status	Published - 2018 Jul
Externally published	Yes

Keywords

diagnostic criteria
guideline
localized scleroderma
severity classification
treatment

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/1346-8138.14161

Cite this

@article{9541150da0d74c9eb9211e2df22b5185,

title = "Diagnostic criteria, severity classification and guidelines of localized scleroderma",

abstract = "We established diagnostic criteria and severity classification of localized scleroderma because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for localized scleroderma, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of localized scleroderma.",

keywords = "diagnostic criteria, guideline, localized scleroderma, severity classification, treatment",

author = "Yoshihide Asano and Manabu Fujimoto and Osamu Ishikawa and Shinichi Sato and Masatoshi Jinnin and Kazuhiko Takehara and Minoru Hasegawa and Toshiyuki Yamamoto and Hironobu Ihn",

note = "Publisher Copyright: {\textcopyright} 2018 Japanese Dermatological Association",

year = "2018",

month = jul,

doi = "10.1111/1346-8138.14161",

language = "English",

volume = "45",

pages = "755--780",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Diagnostic criteria, severity classification and guidelines of localized scleroderma

AU - Asano, Yoshihide

AU - Fujimoto, Manabu

AU - Ishikawa, Osamu

AU - Sato, Shinichi

AU - Jinnin, Masatoshi

AU - Takehara, Kazuhiko

AU - Hasegawa, Minoru

AU - Yamamoto, Toshiyuki

AU - Ihn, Hironobu

PY - 2018/7

Y1 - 2018/7

N2 - We established diagnostic criteria and severity classification of localized scleroderma because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for localized scleroderma, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of localized scleroderma.

AB - We established diagnostic criteria and severity classification of localized scleroderma because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for localized scleroderma, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of localized scleroderma.

KW - diagnostic criteria

KW - guideline

KW - localized scleroderma

KW - severity classification

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85045835447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045835447&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.14161

DO - 10.1111/1346-8138.14161

M3 - Article

C2 - 29687475

AN - SCOPUS:85045835447

SN - 0385-2407

VL - 45

SP - 755

EP - 780

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 7

ER -

Diagnostic criteria, severity classification and guidelines of localized scleroderma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this